» Articles » PMID: 8067515

Detection of Epstein-Barr Viral RNA in Malignant Lymphomas of the Upper Aerodigestive Tract

Overview
Date 1994 Sep 1
PMID 8067515
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Recent studies have suggested a probable etiologic association between Epstein-Barr virus (EBV) and nasal lymphomas, irrespective of geographic location. This study was performed to investigate the strength of association of EBV with non-Hodgkin's lymphomas of the upper aerodigestive tract, based on a large series of cases that have been thoroughly immunophenotyped on frozen tissues. A sensitive in situ hybridization technique was used to detect EBV encoded RNA (EBER) in paraffin sections. Among 30 cases of nasal/nasopharyngeal T-cell lymphoma, 25 (83.3%) were EBER-positive. In the positive cases, most of the neoplastic cells showed strong nuclear signals. Further analysis of this group of tumors showed that all 21 cases (100%) with a CD56+ CD3-phenotype were EBER positive, whereas four of nine cases (44.4%) with a CD56-negative immunophenotype were positive. Only one of 10 cases (10%) of nasal/nasopharyngeal B-cell lymphoma was EBER positive; the positive case was a diffuse mixed-cell lymphoma and could not be distinguished morphologically from the negative cases. Among the 21 cases of lymphoma of the tonsils and back of the tongue (20 B-lineage and one T-lineage), none was EBER positive. In the normal mucosa of the nose/nasopharynx or tonsil (20 cases studied), only very rare EBER-positive small lymphocytes were found in two cases. The almost exclusive detection of EBER in nasal/nasopharyngeal T-cell neoplasms among the lymphomas of the upper aerodigestive tract suggests that EBV probably plays an etiologic role in the pathogenesis of this group of tumors and is not simply a passenger virus, and neither is this merely a site-dependent phenomenon in view of the weak association with nasal/nasopharyngeal B-cell lymphoma.

Citing Articles

Mutational characteristics of extranodal NK/T-cell lymphoma analyzed in relation to clinical prognostic indices.

Lee J, Yoon S, Kim S, Kim W, Cho J Ann Hematol. 2024; 103(12):5749-5757.

PMID: 39589496 DOI: 10.1007/s00277-024-06035-w.


Rhino-Orbital-Cerebral Mycosis and Extranodal Natural Killer or/and T-Cell Lymphoma, Nasal Type.

Li D, Lun L Front Med (Lausanne). 2022; 9:851208.

PMID: 35783622 PMC: 9248758. DOI: 10.3389/fmed.2022.851208.


Extranodal natural killer/T-cell lymphoma of the breast: a retrospective clinicopathological analysis of a consecutive 11-year case series.

Liu W, Chen Z, Li F, Zhang W, Liu W, Zhao S Orphanet J Rare Dis. 2021; 16(1):479.

PMID: 34794461 PMC: 8600691. DOI: 10.1186/s13023-021-02110-x.


What Effect Does Epstein-Barr Virus Have on Extranodal Natural Killer/T-Cell Lymphoma Prognosis? A Review of 153 Reported Cases.

Tvedten E, Richardson J, Motaparthi K Cureus. 2021; 13(9):e17987.

PMID: 34540511 PMC: 8445857. DOI: 10.7759/cureus.17987.


Updating targets for natural killer/T-cell lymphoma immunotherapy.

Xue W, Zhang M Cancer Biol Med. 2021; 18(1):52-62.

PMID: 33628584 PMC: 7877170. DOI: 10.20892/j.issn.2095-3941.2020.0400.